BHA
BIB icon

Beech Hill Advisors’s ProShares Ultra NASDAQ Biotechnology BIB Stock Holding History

Beech Hill Advisors’s Portfolio BIB Stock Details BIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-14,550
Closed -$1.04M – 66
2015
Q4 		$1.04M Buy
14,550
+7,050
+94% +$471K 0.66% 38
2015
Q3 		$437K Buy
+7,500
New +$639K 0.28% 60

Other funds holding BIB

VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
RIA
RPG Investment Advisory Pleasanton, California $829M AUM 36.68% 1-Year Est. Return
OPPM
Opus Point Partners Management New York $55.3M AUM 7.48% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
TH
Timber Hill Greenwich, Connecticut $15.4M AUM 30.7% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Beech Hill Advisors's BIB Position: Q1 2016 in Review

Beech Hill Advisors sold out of ProShares Ultra NASDAQ Biotechnology (BIB) in Q1 2016, closing a stake of 14,550 shares — an estimated $1.04M sold.

Beech Hill Advisors first reported a position in BIB in Q3 2015 and held it in 2 quarters. The position peaked at $1.04M in Q4 2015. 30 funds tracked by Wall St. Rank hold BIB as of Q1 2016.

  • Beech Hill Advisors reported no remaining ProShares Ultra NASDAQ Biotechnology position as of Q1 2016 after selling out during the quarter.
  • Beech Hill Advisors sold 14,550 ProShares Ultra NASDAQ Biotechnology shares in Q1 2016, an estimated $1.04M.
  • Beech Hill Advisors first reported a position in ProShares Ultra NASDAQ Biotechnology in Q3 2015 and held it in 2 quarters.
  • Beech Hill Advisors's ProShares Ultra NASDAQ Biotechnology position peaked at $1.04M in Q4 2015.
  • 30 funds tracked by Wall St. Rank held ProShares Ultra NASDAQ Biotechnology as of Q1 2016.

Based on Beech Hill Advisors's 13F filing for Q1 2016, filed 20 Apr 2016.